starch) clinical trials

French prospective randomised double blind study on aspirin versus placebo in resected colon cancer with PI3K mutation stage III or II high risk (PRODIGE 50 - ASPIK)

This study is looking at whether a low dose of aspirin can help stop colon cancer from coming back in people who have already had surgery. It focuses on those with a specific gene change (PI3K mutation) and a higher risk of the cancer returning. Some people will get aspirin, others a dummy pill.